VBI Vaccines Inc (VBIV)
0.59
-0.02
(-3.04%)
USD |
NASDAQ |
Apr 24, 16:00
0.5874
0.00 (0.00%)
After-Hours: 20:00
VBI Vaccines Profit Margin (Quarterly): -1.52% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.52% |
September 30, 2023 | -308.6% |
June 30, 2023 | -6.20K% |
March 31, 2023 | -5.72K% |
December 31, 2022 | -7.22K% |
September 30, 2022 | -7.95K% |
June 30, 2022 | -13.21K% |
March 31, 2022 | -16.87K% |
December 31, 2021 | -23.19K% |
September 30, 2021 | -14.81K% |
June 30, 2021 | -12.31K% |
March 31, 2021 | -5.86K% |
December 31, 2020 | -9.37K% |
September 30, 2020 | -4.36K% |
June 30, 2020 | -5.17K% |
March 31, 2020 | -2.01K% |
December 31, 2019 | -1.89K% |
September 30, 2019 | -2.50K% |
June 30, 2019 | -2.06K% |
March 31, 2019 | -4.06K% |
December 31, 2018 | -717.2% |
September 30, 2018 | -5.93K% |
June 30, 2018 | -7.15K% |
March 31, 2018 | -6.88K% |
December 31, 2017 | -5.74K% |
Date | Value |
---|---|
September 30, 2017 | -5.08K% |
June 30, 2017 | -2.62K% |
March 31, 2017 | -6.80K% |
December 31, 2016 | -6.14K% |
September 30, 2016 | -2.60K% |
June 30, 2016 | -7.82K% |
March 31, 2016 | -2.25K% |
December 31, 2015 | |
September 30, 2015 | -6.62K% |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-23.19K%
Minimum
Dec 2021
-1.52%
Maximum
Dec 2023
-7.42K%
Average
-5.86K%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -319.4% |
Return on Assets | -82.95% |
Return on Invested Capital | -117.7% |
Gross Profit Margin (Quarterly) | -245.0% |
Operating Margin (Quarterly) | -1.45K% |
Return on Net Operating Assets | -84.55% |